DANIEL HATMAKER: Open Payments
NPI 1366615866 · GALVESTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,593 in 55 payments from 14 companies in 2025. Trend: 2023 $866 · 2024 $992 · 2025 $1,593
Food & beverage: $1,241Travel & lodging: $353
| Company | Payments | Amount |
|---|---|---|
| SPR Therapeutics, Inc | 3 | $382 |
| Abbott Laboratories | 9 | $294 |
| Collegium Pharmaceutical, Inc. | 13 | $228 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $158 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $128 |
| Saluda Medical Americas, Inc. | 3 | $86 |
| Nalu Medical, Inc. | 3 | $58 |
| Lundbeck LLC | 3 | $58 |
| PFIZER INC. | 2 | $52 |
| Valinor Pharma, LLC | 3 | $50 |
Products named: SPRINT PNS System, PROCLAIM, RELISTOR, Belbuca, JOURNAVX, XTAMPZA, Evoke, Nalu Neurostimulation System.
Industry payments across TX — which companies pay providers there.
